Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation

NCT00936884 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Constipation

Interventions

DRUG: Methylnaltrexone
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.

Collaborators

[object Object]